Spravato (esketamine) is an FDA-approved nasal spray used alongside antidepressants to treat treatment-resistant depression. When combined with therapy or oral medications, Spravato may produce faster symptom relief. It can lead to more sustained outcomes than any single treatment, and understanding this combination helps patients seek effective care. Here is more information on this treatment option for improved mental health:
What Is Spravato?
Spravato is the brand name for esketamine, a nasal spray approved by the U.S. Food and Drug Administration (FDA). It is specifically indicated for adults with treatment-resistant depression (TRD), and at least two different antidepressant treatments must have failed to produce adequate results before it is prescribed. Since standard antidepressants are typically taken at home, Spravato differs in that it is administered in a certified healthcare setting under medical supervision.
During the initial treatment phase, patients participate in sessions a few times per week, and they subsequently transition to less frequent maintenance sessions. Spravato carries the potential for dissociation and sedation, so patients remain at the clinic for about two hours after each dose for safety purposes. Consulting a psychiatrist helps determine if this treatment is right for each situation.
How Does It Work?
This treatment targets the NMDA (N-methyl-D-aspartate) receptor, a glutamate receptor in the brain, which sets it apart from traditional antidepressants that act on serotonin, dopamine, or norepinephrine systems. It modulates glutamate activity. Spravato may rapidly promote new neural connections in areas of the brain associated with mood regulation; this mechanism represents a fundamentally different approach to treating depression. One of the most notable characteristics of this treatment is the speed at which it helps reduce depressive symptoms.
How Are Other Treatments Complemented?
Spravato is not intended to replace existing treatments; it is designed to work alongside them. The FDA requires that Spravato be used in conjunction with an oral antidepressant, not as a standalone therapy, which means patients continue their current medication regimens while adding Spravato to their care plan. This combination approach addresses multiple neurotransmitter pathways simultaneously. It may produce more comprehensive outcomes as a result.
Therapy is sometimes paired with this treatment. Because Spravato may promote rapid neuroplasticity, it creates a window during which the brain is more receptive to learning new thought patterns. Patients who engage in psychotherapy during or shortly after treatment sessions may benefit from this heightened state of neural adaptability, and coordinating session timing with a psychiatrist and therapist helps maximize this effect.
Medication management also plays a role in treatment outcomes. Psychiatrists may adjust oral antidepressant regimens based on how a patient responds to Spravato over time; these adjustments allow for a more individualized approach. Although each patient’s response will vary, open communication among all treating providers helps the treatment plan remain responsive and precise.
What Are the Benefits?
Combining Spravato with complementary treatments offers several advantages for patients with treatment-resistant depression, including:
- Faster symptom relief
- Broader neurological impact
- Enhanced therapeutic receptivity
The combination approach also reduces reliance on any one treatment. When multiple therapies work together, the overall treatment plan becomes more resilient to fluctuations in a patient’s condition.
Improve Your Mental Health Now
Spravato represents a valuable development in the treatment of resistant depression, particularly when used alongside oral antidepressants and therapy. Its unique mechanism of action complements existing treatments rather than competing with them; for patients who have struggled to find relief through conventional medications, a combined approach may offer a more effective plan. If you are looking to improve your mental health, speak with a psychiatrist.
